NCT07283029Active, not recruiting
Activity and Cancer Survivorship Exercise Pilot
Evaluating Changes in Functional Fitness Following a 10-Week Home-Based Comprehensive Exercise Program in Endometrial Cancer Patients Who Have Completed Treatment
Source: ClinicalTrials.gov · Last updated 15 Dec 2025
Brief summary (registry, in English)
This early phase I clinical trial measures the changes in functional fitness following home-based comprehensive exercise program in patients who have endometrial cancer who have completed treatment. Endometrial cancer is an increasingly common diagnosis, with health and quality of life concerns persisting after the active cancer treatment period. Exercise in cancer survivors has the potential to reduce the risk of death by improving cardiovascular fitness, quality of life, strength, longevity, and independence. A home-based exercise programs may be a feasible approach for exercise programming in patients who have endometrial cancer who have completed treatment.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 20 Nov 2025
- Start date
- 9 Feb 2023
- Primary completion date
- 6 Dec 2023
- Lead sponsor
- University of Iowa
- Diseases
- Endometrial cancer
- NCT number
- NCT07283029
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 9 Feb 2023 to the primary completion date, 6 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Enrolled in another clinical trial or has used of any investigational drugs, biologics, or devices within 30 days prior to randomization
Other illness
- Absolute contraindications to exercise (i.e., acute myocardial infarction, severe orthopedic or musculoskeletal limitations
- Have evidence of recurrent or metastatic disease
- Report of chest pain, shortness of breath, fainting, or angina pectoris
Other
- Are currently performing resistance training \>= 2 days per week
- Are currently exceeding 150 minutes of at least moderate intensity activity per week
- Have physical disability that would limit range of motion through exercises such as sitting, standing and inability to walk one block
- Plans to move from the area
- Women who are pregnant or breast-feeding
- Not suitable for study participation due to other reasons at the discretion of the investigator
- Failing the Physical Activity Readiness Questionnaire
Who the study is looking for
- Willing to provide written informed consent
- Willing to comply with all study procedures and be available for the duration of the study
- Fluent in spoken and written English
- Women 18-74 years of age
- Documented diagnosis of type I, stage I-IIIc endometrial cancer within the past 5 years
- Completion of current treatment for endometrial cancer
- Technology access (cellphone with data, broadband internet, WiFi) for tele coaching
- Pass the Physical Activity Readiness Questionnaire (PAR-Q)
Age in the registry: 18 years to 74 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Iowa Coordinator of this site? Confirm its status | Iowa City | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.